Advertisement
Advertisement

More Related Content

Advertisement

More from El día después será...(20)

Advertisement

COVID-19: The Day Before | Lessons from SARS, Ebola, Nipah – how our relationship with other animals got us here

  1. Session 01: Environment and health community: “The day before” Júlia Vergara-Alert, DVM, PhD julia.vergara@irta.cat Lessons from SARS, Ebola, Nipah – how our relationship with other animals got us here Webinar -April 28, 2020
  2. Session 01: Environment and health community: “The day before” Lessons from SARS, Ebola and Nipah – how our relationship with other animals got us here How are diseases transmitted between animal species, including humans? Animal-human diseases interconnection
  3. Zoonotic diseases >60% of all known human infectious diseases Source: FCRNfood source
  4. https://foodsource.org.uk/sites/default/files/chapters/p dfs/foodsource_chapter_11.pdf Routes for diseases transmission: • Direct contact with animal bodily fluids (saliva, faeces, blood) via: • Touching an infected animal’s skin; • Being bitten by an infected animal. • Indirect contact within areas where infected animals live and roam, including: • Consuming contaminated food products; • Contact with contaminated water, soil, objects or clothing. • Disease vectors: organisms that transmit infectious disease between animals, and between animals and humans.
  5. Disease emergence, re-emergence, persistence Human living environments • Increasing population density • Increasing mobility • Growing poverty • Changing dietary habits • Lack of infrastructure Food and agricultural systems • Expanding agricultural production • Globalization of production • Peri-urban livestock production • Trade in live animals and animal product Natural ecosystems • Land use • Deforestation • Climate change • Biodiversity loss • Huting, poaching, trade • Unregulated tourism Disease interactions at the human-livestock-ecosystem interface
  6. Session 01: Environment and health community: “The day before” Lessons from SARS, Ebola and Nipah – how our relationship with other animals got us here How do animal diseases become human diseases?
  7. The severity of infection for viruses often increases with each step away from the original host species The emergence of a virus Virus Type represented: Coronavirus Animal reservoir Bats, for Ebola and SARS-, MERS-CoV Intermediate hosts Civets in the case of SARS-CoV Transmission to humans, and H2H The virus can adapt and mutate Dissemination Increasing mobile population Species barrier Species barrier Source: Institut Pasteur
  8. Nipah virus transmission
  9. Ebola virus transmission Humans are infected by close contact with the blood, secretions, organs or other bodily fluids of infected animals Ebola then spreads through H2H transmission, with infection resulting from direct contact throufh broken skin or mucus or bodily fluids of infected animals Pigs Antelopes Chimpanzees Gorillas In Africa a particular species of fruit bat is considered to be the posible host for Ebola virus Secondary hosts Primary host fruit bat
  10. Session 01: Environment and health community: “The day before” Lessons from SARS, Ebola and Nipah – how our relationship with other animals got us here What do we know from SARS-CoV-2?
  11. https://www.dpz.eu/en/home/single-view/news/die-vermehrung-von- sars-coronavirus-2-im-menschen-verhindern.html Human coronaviruses
  12. • SARS-CoV-2 and bat CoV RaTG13 identity: 96% (Zhou et al., 2020) https://phys.org/news/2019-08-species-horseshoe-scientists-thought.html SARS-CoV-2 origin
  13. Intermediate hosts “Based on our analyses and existing data of coronaviruses, we concluded that the intermediate hosts of 2019-nCoV are more likely to be mammals and birds than snakes...” (Zhang et al., 2020b) Currently, bioinformatics and sequencing have suggested: Pangolín (Zhang et al., 2020b) Tortugas (Liu et al., 2020) Jineta y pollos (Veljkovic et al., 2020) ?
  14. Júlia Vergara-Alert, DVM, PhD julia.vergara@irta.cat
  15. • SARS-CoV-2 local isolates • in vitro tests to test antivirals and antibodies • Set up animal models of COVID-19: • To study pathogenesis • Test drugs/vaccines in vivo Consortium financed by GRIFOLS
Advertisement